Abcellera Biologics Inc
NASDAQ:ABCL
Abcellera Biologics Inc
Operating Income
Abcellera Biologics Inc
Operating Income Peer Comparison
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Abcellera Biologics Inc
NASDAQ:ABCL
|
Operating Income
-$237.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-212%
|
CAGR 10-Years
N/A
|
|
Arch Biopartners Inc
XTSX:ARCH
|
Operating Income
-CA$5.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-38%
|
|
Replicel Life Sciences Inc
XTSX:RP
|
Operating Income
-CA$1.4m
|
CAGR 3-Years
12%
|
CAGR 5-Years
11%
|
CAGR 10-Years
N/A
|
|
Innovotech Inc
XTSX:IOT
|
Operating Income
-CA$219.6k
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
13%
|
See Also
What is Abcellera Biologics Inc's Operating Income?
Operating Income
-237.2m
USD
Based on the financial report for Dec 31, 2023, Abcellera Biologics Inc's Operating Income amounts to -237.2m USD.
What is Abcellera Biologics Inc's Operating Income growth rate?
Operating Income CAGR 5Y
-212%